Last updated at 03 Jul 2024 12:30 AM
Director
DIN: 09140945
Mani Vigneshwaran is currently associated with 2 companies in various capacities such as Additional Director, Director and Individual Promoter. They serve as a Director at SPEROGENX BIOSCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09140945.Mani Vigneshwaran is currently involved in 3 different roles. Their most recent position is with ELSCION BIOMEDICALS PRIVATE LIMITED as a Director. The first company Mani Vigneshwaran was appointed to as a director was SPEROGENX BIOSCIENCES PRIVATE LIMITED. Mani Vigneshwaran is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Mani Vigneshwaran is currently associated with 2 companies in various capacities such as Additional Director, Director and Individual Promoter. They serve as a Director at SPEROGENX BIOSCIENCES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09140945.Mani Vigneshwaran is currently involved in 3 different roles. Their most recent position is with ELSCION BIOMEDICALS PRIVATE LIMITED as a Director. The first company Mani Vigneshwaran was appointed to as a director was SPEROGENX BIOSCIENCES PRIVATE LIMITED. Mani Vigneshwaran is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1 Year 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SPEROGENX BIOSCIENCES PRIVATE LIMITED | Additional Director | 10-Apr-2021 |
| ELSCION BIOMEDICALS PRIVATE LIMITED | Director | 05-Aug-2022 |
| ELSCION BIOMEDICALS PRIVATE LIMITED | Individual Promoter | 05-Aug-2022 |